Prevalence of Toxoplasma gondii and Toxocara canis among Patients with Uveitis

Ocular Immunology and Inflammation

Volumn 23, Issue 2, 2015, Pages 111-117

  Lim, Su Jin ^a   Lee, Sang Eun ^b   Kim, Sun Hyun ^a   Hong, Sung Hee ^b   You, Yong Sung ^a   Kwon, Oh Woong ^a   Kim, Hyeun Seung ^c  

^a NUNE Eye Hospital   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Ocular toxocariasis; Ocular toxoplasmosis; Parasite; Serologic test; Uveitis

Indexed keywords

IMMUNOGLOBULIN G; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; AQUEOUS HUMOR; ARTICLE; BLOOD ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOMA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RETINITIS; SCAR FORMATION; SEROLOGY; TOXOCARA CANIS; TOXOCARIASIS; TOXOPLASMA GONDII; UVEITIS; VERY ELDERLY; VITRITIS; ANIMAL; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PARASITOLOGY; PROSPECTIVE STUDY; SOUTH KOREA; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; AQUEOUS HUMOR; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; TOXOCARA CANIS; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; UVEITIS;

EID: 84928641710     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.839798     Document Type: Article

References (34)

1. Hwang DK, Chou YJ, Pu CY, et al. Epidemiology of uveitis among the Chinese population in Taiwan: a populationbased study. Ophthalmology. 2012;119:2371-2376.
2. Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297-310.
3. Em D. Focal points: clinical modules for ophthalmologists. In Ocular Toxoplasmosis: Clinical Presentation, Diagnosis and Therapy. San Francisco: American Academy of Ophthalmology; 1999.
4. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121:35-46.
5. Stewart JM, Cubillan LD, Cunningham Jr ET. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina. 2005;25:1005-1013.
6. Kijlstra A, Eissen OA, Cornelissen J, et al. Toxoplasma gondii infection in animal-friendly pig production systems. Invest Ophthalmol Vis Sci. 2004;45:3165-3169.
7. Rothova A, de Boer JH, Ten Dam-van Loon NH, et al. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Ophthalmology. 2008;115:306-311.
8. Westeneng AC, Rothova A, de Boer JH, et al. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol. 2007;144:781-785.
9. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO Report 2011.
10. Candolfi E, Pastor R, Huber R, et al. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis. 2007;58:83-88.
11. Gallian P CP, Bellafronte M-H, Dallibert C, Zappitelli P-P, De Micro P. Evaluation de l'automate complet EVOLIS (Bio-Rad) dans un contexte transfusionnel: aspects organisationnels et sécuritaires. La Gazette de la Transfusion n2003.
12. Griffais R, Andre PM, Thibon M. K-tuple frequency in the human genome and polymerase chain reaction. Nucleic Acids Res. 1991;19:3887-3891.
13. Borecka A, Gawor J. Modification of gDNA extraction from soil for PCR designed for the routine examination of soil samples contaminated with Toxocara spp. eggs. J Helminthol. 2008;82:119-122.
14. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844-848.
15. Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432-435.
16. Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277-286.
17. Arcinue CA, Ceron OM, Foster CS. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther. 2013 (Epub 8 Jan 2013).
18. Jaffe GJ, Martin D, Callanan D, et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology. 2006;113:1020-1027.
19. Saraiya NV, Goldstein DA. Dexamethasone for ocular inflammation. Expert Opin Pharmacother. 2011;12:1127-1131.
20. Maetz HM, Kleinstein RN, Federico D, et al. Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis. 1987;156:414.
21. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136-144.
22. Lim H, Lee SE, Jung BK, et al. Serologic survey of toxoplasmosis in Seoul and Jeju-do, and a brief review of its seroprevalence in Korea. Korean J Parasitol. 2012;50: 287-293.
23. Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol. 1984;28:361-381.
24. Schantz PM, Weis PE, Pollard ZF, et al. Risk factors for toxocaral ocular larva migrans: a case-control study. Am J Public Health. 1980;70:1269-1272.
25. Pivetti-Pezzi P. Ocular toxocariasis. Int J Med Sci. 2009;6: 129-130.
26. Gillespie SH, Dinning WJ, Voller A, et al. The spectrum of ocular toxocariasis. Eye (Lond). 1993;7:415-418.
27. Park HY, Lee SU, Huh S, et al. A seroepidemiological survey for toxocariasis in apparently healthy residents in Gangwon-do, Korea. Korean J Parasitol. 2002;40:113-117.
28. de Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008;145:369-374.
29. Glickman LT, Magnaval JF, Domanski LM, et al. Visceral larva migrans in French adults: a new disease syndrome? Am J Epidemiol. 1987;125:1019-1034.
30. Taylor MR, Keane CT, O'Connor P, et al. The expanded spectrum of toxocaral disease. Lancet. 1988;1:692-695.
31. Garza-Leon M, Garcia LA. Ocular toxoplasmosis: clinical characteristics in pediatric patients. Ocul Immunol Inflamm. 2012;20:130-138.
32. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265-272.
33. Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol. 2001;75:299-305.
34. Yokoi K, Goto H, Sakai J, et al. Clinical features of ocular toxocariasis in Japan. Ocul Immunol Inflamm. 2003;11: 269-275.